



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Tuesday,
                        12 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    HEALTH AND FAMILY WELFARE






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

4976






                                    ANSWERED ON: 
                                

01.04.2022






Safety and Efficacy Data of Corbevax Vaccine




Deepak (Dev) Adhikari














                        Will the Minister of





HEALTH AND FAMILY WELFARE


                        be pleased to state:-















                                                    (a)	whether the Government has given approval to a new COVID-19 vaccine named Corbevax for vaccinating children in the age group 12-14 year, after ascertaining the safety and efficacy data of the vaccine, if so, the details thereof;(b)	 whether the data on the above vaccine has been peer reviewed, if so, the details thereof;(c)	 whether the use of Corbevax in the above age group is yet to be approved by NTAGI, if so, the details thereof;(d)	 whether the protein sub unit used in the vaccine is from the wild Wuhan type SARS-CoV-2 virus, if so, the details thereof; and(e)	whether the Government has any data regarding its efficacy against omicron and other variants, if so, the details thereof? 






ANSWER




                                                        THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE(DR. BHARATI PRAVIN PAWAR)(a) to (e) Based on the interim safety & immunogenicity data of Phase II/III clinical trial conducted in subjects of = 5 to <18 years age group, Central Drugs Standard Control Organisation (CDSCO), the National Regulator in consultation with Subject Expert Committee (SEC) has granted permission to manufacture SARS-CoV-2 vaccine [CORBEVAX] of M/s Biological E Limited for restricted use in emergency situation in = 12 to <18 years age group.Peer review of clinical trial results of specific vaccines are usually done by domain knowledge experts and scientists who have developed and manufactured these vaccines or who have knowledge of such vaccines and vaccination process. Government of India has expanded the COVID-19 vaccination to beneficiaries aged 12-14 years from 16th March 2022 on the recommendation of domain knowledge experts.CORBEVAX vaccine has been tested for Neutralizing Antibody (nAb) Titers against Wuhan, Delta and Beta variants in its Phase II/III clinical trial & Phase III (immunogenic superiority) clinical trial conducted in the country & its reported to be immunogenic. The potential impact of Omicron variant on existing countermeasures including vaccine is scrutinized by technical groups worldwide. Vaccines used in National Covid-19 Vaccination Program remain effective to prevent the risk of severity due to COVID-19.*******
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113264884







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







